Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · August 16, 2012

Forgoing Resection of Primary Tumor in Metastatic Colon Cancer

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Primary mFOLFOX6 Plus Bevacizumab Without Resection of the Primary Tumor for Patients Presenting With Surgically Unresectable Metastatic Colon Cancer and an Intact Asymptomatic Colon Cancer
J. Clin. Oncol 2012 Aug 06;[EPub Ahead of Print], LE McCahill, G Yothers, S Sharif, NJ Petrelli, LL Lai, N Bechar, JK Giguere, SR Dakhil, L Fehrenbacher, SH Lopa, LD Wagman, MJ O’Connell, N Wolmark

Further Reading